Welcome to the Future

In an industry where timing, logistics, and attendee engagement must harmonize perfectly, event organizing is no longer just about coffee, clipboards, and charisma. Technology is playing an increasingly central role — not just streamlining operations but reshaping the very nature of what events can be.

Creating an ideal method to faithfully represent the human body, including its organs and tissues, has posed a significant challenge and remains a sought-after achievement in medicine since its inception. Although not flawless, organoids are advancing us toward achieving this objective.

In Part 2 of our interview with Jonas Bjerg, we shift from the individual to the institutional—exploring how generative AI is transforming entire industries, reshaping workforce skills, and raising complex ethical and regulatory challenges. From real-world applications in healthcare and marketing to the importance of human oversight and thoughtful policy, Jonas offers a grounded perspective on what it takes to adopt AI responsibly and where it’s all heading.

Generative AI is fast weaving itself into the fabric of our society. While many remain skeptical about its rapid adoption and the potential consequences it poses on an economic and social scale, Jonas Bjerg, author of “The Early-Career Professional’s Guide to Generative AI”, separates fact from fiction—offering a grounded view on how we can live alongside AI and how our interaction with it might evolve.

What used to be considered a hobby for kids and teens has become one of the most dynamic, innovative, and lucrative sectors in tech today. Video games are no longer just about high scores or pixelated quests. They’ve grown into immersive, cinematic, and social experiences that are influencing how we play, learn, and connect.

The rise of live biotherapeutic products is reshaping healthcare by using live microorganisms to restore and maintain a balanced microbiota or to serve in targeted drug delivery. Companies like NeribiOm, EverImmune, Azitra, Siolta Therapeutics, and P. Happi are leading the way in developing treatments for a wide range of conditions. Their efforts highlight the significant potential of microbiome-based therapies to provide targeted and effective treatments.